“With all the advances in source data generation technology paper can no longer be considered the norm.”
Authors:
Ale Gicqueau, President & Chairman , ClinCapture
  • Learn the benefits of eSource compared to standard paper source
  • Explore the challenges of eSource adoption
  • Understand the position of the Food and Drug Administration the topic of eSource data
  • Gain understanding on how far technology can support the expansion of eSource
Abstract: eSource (or electronic source data) is up and coming in the healthcare and clinical trial industry. Electronic Data Capture (EDC), Electronic Health Records (EHR) and Electronic Submission (eCTD) are more well-known and have a wider understanding within the industry than eSource does. The goal of this white paper is to clarify the concept of eSource as it relates to clinical trials. What are the benefits of eSource compared to standard paper source? How can we explain the challenges of eSource adoption and the position of the Food and Drug Administration (FDA) on the topic? How far can technology support the expansion of eSource?